Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?
Transgelin is a 22-kDa protein involved in cytoskeletal organization and expressed in smooth muscle tissue. According to animal studies, it is a potential mediator of kidney injury and fibrosis, and moreover, its role in tumorigenesis is emerging in a variety of cancers. The study included 126 ambul...
Main Authors: | Karolina Woziwodzka, Jolanta Małyszko, Ewa Koc-Żórawska, Marcin Żórawski, Paulina Dumnicka, Artur Jurczyszyn, Krzysztof Batko, Paulina Mazur, Małgorzata Banaszkiewicz, Marcin Krzanowski, Paulina Gołasa, Jacek A. Małyszko, Ryszard Drożdż, Katarzyna Krzanowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/1/79 |
Similar Items
-
Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients
by: Karolina Woziwodzka, et al.
Published: (2021-12-01) -
The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment
by: Małgorzata Banaszkiewicz, et al.
Published: (2022-03-01) -
Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma
by: Małgorzata Banaszkiewicz, et al.
Published: (2020-01-01) -
Evolution and function of calponin and transgelin
by: Tzu-Bou Hsieh, et al.
Published: (2023-06-01) -
Serum transgelin is a novel prognostic biomarker for COVID-19 patients
by: Lei Gao, et al.
Published: (2024-11-01)